Welcome to our dedicated page for Standex Intl SEC filings (Ticker: SXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Standex International Corporation filings document the reporting obligations of a diversified industrial manufacturer with operations across Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions. Form 8-K filings furnish quarterly results, segment performance commentary, order trends, portfolio actions, leverage updates, and exhibits tied to earnings releases.
The company’s proxy and governance filings cover director elections, advisory executive compensation votes, auditor ratification, board matters, and executive compensation disclosures. Other current reports record officer transitions and related management changes, providing formal disclosure on governance, leadership structure, financial reporting, and capital-allocation matters.
Standex International Corporation (SXI) reported an insider transaction by a company director. On 11/20/2025, the director sold 1,000 shares of Standex common stock in an open-market transaction coded "S" at a price of $223.31 per share. After this sale, the director beneficially owns 13,229 shares of Standex common stock, held directly.
SXI has a Form 144 notice indicating a planned sale of 1,000 shares of common stock, with an aggregate market value of $223,310.10, through Fidelity Brokerage Services LLC on the NYSE around 11/20/2025. These shares were acquired on 10/25/2025 via restricted stock vesting from the issuer as compensation.
The filing lists 12,116,999 shares of this class as outstanding, providing context for the size of the planned sale. No other sales by this person during the past three months are shown in the excerpt. By signing, the seller represents they are not aware of undisclosed material adverse information about SXI’s operations.
Standex International Corporation director reports stock purchase
A director of Standex International Corporation reported buying 1,500 shares of common stock on 08/29/2025 at a price of $205 per share. After this transaction, the director beneficially owns 6,000 shares of Standex common stock in direct ownership.
This report is an amendment that clarifies the transaction code, explaining that the original report inadvertently used a different code and that the transaction should be classified as a purchase.
Standex International Corporation (SXI) director transaction: A company director reported buying 2,000 shares of Standex common stock on 08/25/2025 at a price of $209.4959 per share. After this purchase, the director directly owns 4,500 shares of Standex common stock. This filing is an amended Form 4 that corrects the original report, which had mistakenly used transaction code "A"; the transaction is now shown as code "P", indicating an open market or private purchase.
Standex International (SXI) reported insider equity awards for its Chief HR Officer & VP on 11/10/2025. The filing shows an acquisition of 630 shares of common stock from a restricted stock grant, with 630 shares beneficially owned directly after the transaction.
The officer also received 378 Performance Share Units that cliff vest after a three‑year period, with the ultimate payout ranging from 0% to 250% of the award based on company performance metrics. In addition, 378 Restricted Stock Units were granted, scheduled to vest one‑third on August 23, 2026, one‑third on August 23, 2027, and one‑third on August 23, 2028.
Standex International (SXI) filed a Form 3 for a new insider. The reporting person is an officer, listed as Chief HR Officer & VP, with an event date of 11/10/2025. The filing states that no securities are beneficially owned by the officer at this time. This is an initial ownership report and reflects that the insider held no Standex stock or derivative securities when the reporting obligation began.
Standex International (SXI) announced leadership changes in human resources. The Board accepted the resignation of Chief Human Resources Officer and named executive officer Annemarie Bell, effective November 10, 2025. She will transition to a role focused on executive coaching and leadership development, supporting an organizational need while addressing a significant health challenge.
Effective the same date, the Board appointed Michelle Newbury as Chief Human Resources Officer. Newbury, age 46, will lead global HR strategy, including talent management, organizational development, compensation and benefits, diversity and inclusion, and employee engagement initiatives.
Standex International (SXI) reported an insider transaction by its Chief Strategy Officer. On November 5, 2025, the reporting person sold 650 shares of common stock at a weighted average price of $233.37.
After the transaction, the insider beneficially owns 5,047 shares, held directly. The filing notes the sale occurred in multiple trades within a price range of $232.91 to $233.865, and detailed trade breakdowns are available upon request.
SXI: A holder filed a Form 144 notice to sell up to 650 shares of common stock. The filing lists an aggregate market value of $151,714.10, an approximate sale date of 11/05/2025, and identifies Fidelity Brokerage Services LLC as broker, with sales on the NYSE.
The shares were acquired via restricted stock vesting from the issuer on 10/26/2024 as compensation. Shares outstanding were 12,116,999; this is a baseline figure, not the amount being offered.
Standex International (SXI) executive reported an insider sale. The Vice President/CFO/Treasurer sold 1,823 shares of common stock on 11/04/2025, coded S (sale) on Form 4. The transaction was reported at a weighted average price of $230.12, with individual trades executed between $229.66 and $230.23.
Following the sale, the reporting person directly beneficially owns 9,341 shares. The filing notes the seller will provide full pricing breakdowns upon request.